Health Care Systems

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…

For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…

We’ve previously posted about the risks confronting older adults when they are hospitalized– whether due to infections, disrupted sleep, delirium, or even falls due to sedentary behavior while hospitalized. Moreover, during the pandemic, doctors, patients, and healthcare systems all struggled to lessen the number of patients heading to hospitals, as…